All Posts
Martha Ann Auble Alderman
Martha Ann Auble Alderman passed away peacefully in her sleep on Wednesday, July 31 after a brief, but hard-fought battle…
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Study Name Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene ClinicalTrials.gov Identifier…
A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients with Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers
Study Name • A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating…
Olga Mech
It is with profound sadness that the family announce the passing of Olga, lifelong beloved wife, mother and grandmother and…
A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients with Cholangiocarcinoma
Study Name A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients with Cholangiocarcinoma ClinicalTrials.gov Identifier (if applicable)…
Helping Bile Duct Cancer Patients Find Specialists Nationwide
Read the full article by clicking here.
2019 Annual Conference Videos
All of the presentations at our 2019 Annual Conference are online and waiting to be viewed! Visit our Conference in Review page…
Keynote Presentation from the 2019 CCF Annual Conference
Advancing technologies and the tipping point for Medicine Vivek Wadhwa, Keynote Speaker
The Cholangiocarcinoma Foundation Announces New Scientific and Medical Advisory Board
Read the full article by clicking here.
Vivek Wadhwa Announced as Cholangiocarcinoma Foundation Annual Conference Keynote Speaker
Read the full article by clicking here.